{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:27:21Z","timestamp":1786973241637,"version":"build-2736575974"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1105008"],"award-info":[{"award-number":["1105008"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1195955"],"award-info":[{"award-number":["1195955"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2015727"],"award-info":[{"award-number":["2015727"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.neubiorev.2025.106427","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T23:27:28Z","timestamp":1760570848000},"page":"106427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pharmacological and dietary treatments for developmental stuttering: A systematic review"],"prefix":"10.1016","volume":"179","author":[{"given":"Sarah E.","family":"Horton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elana J.","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid E.","family":"Scheffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy A.","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1147-7405","authenticated-orcid":false,"given":"Angela T.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neubiorev.2025.106427_bib1","first-page":"47","article-title":"Efficacy of addition of atomoxetine to speech therapy in stuttering severity of children aged 4-12 years: a Double-Blind randomized controlled trial","volume":"16","author":"Ahmadabadi","year":"2022","journal-title":"Iran. J. Child Neurol."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106427_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1370\/afm.238","article-title":"Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication","volume":"3","author":"Aikens","year":"2005","journal-title":"Ann. Fam. Med."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106427_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/br.2022.1515","article-title":"Green tea consumption and the management of adrenal stress hormones in adolescents who stutter","volume":"16","author":"Almudhi","year":"2022","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.neubiorev.2025.106427_bib4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijporl.2018.06.045","article-title":"The concentrations of bioelements in the hair samples of Jordanian children who stutter","volume":"112","author":"Alqhazo","year":"2018","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106427_bib5","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1176\/ajp.152.7.1087","article-title":"Lack of effect of clonidine on stuttering in children","volume":"152","author":"Althaus","year":"1995","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106427_bib6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.braindev.2016.09.001","article-title":"ACTH has beneficial effects on stuttering in ADHD and ASD patients with ESES: a retrospective study","volume":"39","author":"Altunel","year":"2017","journal-title":"Brain Dev."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106427_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0094-730X(77)90025-0","article-title":"Haloperidol and the treatment of stuttering","volume":"2","author":"Andrews","year":"1977","journal-title":"J. Fluen. Disord."},{"key":"10.1016\/j.neubiorev.2025.106427_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.101718","article-title":"Neurofilament-lysosomal genetic intersections in the cortical network of stuttering","volume":"184","author":"Benito-Arag\u00f3n","year":"2020","journal-title":"Prog. Neurobiol."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106427_bib9","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1044\/2021_JSLHR-21-00236","article-title":"Anxiety and depression symptoms in children and adolescents who stutter: a systematic review and meta-analysis","volume":"65","author":"Bernard","year":"2022","journal-title":"J. Speech Lang. Hear. Res."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106427_bib10","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1044\/1058-0360(2006\/032)","article-title":"Stuttering treatment research 1970-2005: II. Systematic review incorporating trial quality assessment of pharmacological approaches","volume":"15","author":"Bothe","year":"2006","journal-title":"Am. J. SpeechLang. Pathol."},{"issue":"10","key":"10.1016\/j.neubiorev.2025.106427_bib11","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/dmcn.15211","article-title":"Self-reported impact of developmental stuttering across the lifespan","volume":"64","author":"Boyce","year":"2022","journal-title":"Dev. Med. Child Neurol."},{"issue":"10","key":"10.1016\/j.neubiorev.2025.106427_bib12","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1176\/ajp.148.10.1309","article-title":"The pharmacology of stuttering: a critical review","volume":"148","author":"Brady","year":"1991","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106427_bib13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00004714-200004000-00037","article-title":"Alprazolam, citalopram, and clomipramine for stuttering","volume":"20","author":"Brady","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106427_bib14","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/0006-3223(90)90544-C","article-title":"Verapamil in stuttering","volume":"27","author":"Brady","year":"1990","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106427_bib15","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/0006-3223(89)90224-2","article-title":"A trial of verapamil in the treatment of stuttering in adults","volume":"25","author":"Brady","year":"1989","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106427_bib16","article-title":"Interventions for children and adolescents who stutter: a systematic review, meta-analysis, and evidence map","volume":"70","author":"Brignell","year":"2021","journal-title":"J. Fluen. Disord."},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106427_bib17","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1212\/WNL.44.12.2262","article-title":"Laryngeal botulinum toxin injections for disabling stuttering in adults","volume":"44","author":"Brin","year":"1994","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106427_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/13682828809019875","article-title":"A double-blind study of verapamil in the treatment of stuttering","volume":"23","author":"Brumfitt","year":"1988","journal-title":"Br. J. Disord. Commun."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106427_bib19","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1044\/2021_AJSLP-21-00107","article-title":"Consensus guidelines for the assessments of individuals who stutter across the lifespan","volume":"30","author":"Brundage","year":"2021","journal-title":"Am. J. SpeechLang. Pathol."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106427_bib20","first-page":"255","article-title":"The acute effect of haloperidol and apomorphine on the severity of stuttering","volume":"13","author":"Burns","year":"1978","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106427_bib21","article-title":"Developmental stuttering and the role of the supplementary motor cortex","volume":"64","author":"Busan","year":"2020","journal-title":"J. Fluen. Disord."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106427_bib22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/WNF.0b013e31819817eb","article-title":"Investigating the efficacy of paroxetine in developmental stuttering","volume":"32","author":"Busan","year":"2009","journal-title":"Clin. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106427_bib23","first-page":"193","article-title":"Effetto del trattamento farmacologico nella balbuzie evolutiva: studio comportamentale di un caso singolo","volume":"35","author":"Busan","year":"2008","journal-title":"G. Ital. di Psicol."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106427_bib24","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1177\/1073858418803594","article-title":"Functional and neuroanatomical bases of developmental stuttering: current insights","volume":"25","author":"Chang","year":"2019","journal-title":"Neuroscientist"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106427_bib25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/104012371702900306","article-title":"A case series on the effectiveness of lurasidone in patients with stuttering","volume":"29","author":"Charoensook","year":"2017","journal-title":"Ann. Clin. Psychiatry. Off. J. Am. Acad. Clin. Psychiatr."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106427_bib26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bandl.2013.05.016","article-title":"Computational modeling of stuttering caused by impairments in a basal ganglia thalamo-cortical circuit involved in syllable selection and initiation","volume":"126","author":"Civier","year":"2013","journal-title":"Brain Lang."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106427_bib27","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00004714-199512000-00011","article-title":"Sertraline in stuttering","volume":"15","author":"Costa","year":"1995","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2025.106427_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jfludis.2014.01.001","article-title":"Trait and social anxiety in adults with chronic stuttering: conclusions following meta-analysis","volume":"40","author":"Craig","year":"2014","journal-title":"J. Fluen. Disord."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106427_bib29","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/00005053-195906000-00007","article-title":"An exploratory investigation of the effect of meprobamate on stuttering behavior","volume":"128","author":"Di Carlo","year":"1959","journal-title":"J. Nerv. Ment. Dis."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106427_bib30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/WNF.0b013e31822b9ead","article-title":"Psychiatric disorders in a patient with persistent developmental stuttering","volume":"34","author":"Dias","year":"2011","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.neubiorev.2025.106427_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.692568","article-title":"Drug-induced stuttering: occurrence and possible pathways","volume":"12","author":"Ekhart","year":"2021","journal-title":"Front. Psychiatry"},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106427_bib32","doi-asserted-by":"crossref","first-page":"364","DOI":"10.7326\/0003-4819-144-5-200603070-00013","article-title":"Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement","volume":"144","author":"Gagnier","year":"2006","journal-title":"Ann. Intern. Med."},{"issue":"13","key":"10.1016\/j.neubiorev.2025.106427_bib33","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1503\/cmaj.1041064","article-title":"Modern antipsychotic drugs: a critical overview","volume":"172","author":"Gardner","year":"2005","journal-title":"CMAJ"},{"issue":"8S","key":"10.1016\/j.neubiorev.2025.106427_bib34","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1044\/2019_JSLHR-S-CSMC7-18-0356","article-title":"Neuroanatomical correlates of childhood stuttering: MRI indices of White and gray matter development that differentiate persistence versus recovery","volume":"62","author":"Garnett","year":"2019","journal-title":"J. Speech Lang. Hear. Res."},{"key":"10.1016\/j.neubiorev.2025.106427_bib35","article-title":"Adult stuttering prevalence II: recalculation, subgrouping and estimate of stuttering community engagement","author":"Gattie","year":"2024","journal-title":"J. Fluen. Disord."},{"issue":"14","key":"10.1016\/j.neubiorev.2025.106427_bib36","first-page":"653","article-title":"Meprobamate in the therapy of stuttering children","volume":"22","author":"Gebelt","year":"1967","journal-title":"Meprobamat Behandl. stotternder Kinder"},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106427_bib37","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1044\/2018_JSLHR-S-17-0353","article-title":"Stuttering and labor market outcomes in the United States","volume":"61","author":"Gerlach","year":"2018","journal-title":"J. Speech Lang. Hear. Res."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106427_bib38","first-page":"1","article-title":"Efficacy of levetiracetam in treatment of childhood stuttering [Article]","volume":"11","author":"Ghazavi","year":"2020","journal-title":"Int. J. Prev. Med."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106427_bib39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0094-730X(03)00005-6","article-title":"Parkinsonian speech disfluencies: effects of L-dopa-related fluctuations","volume":"28","author":"Goberman","year":"2003","journal-title":"J. Fluen. Disord."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106427_bib40","first-page":"238","article-title":"A double-blind comparison of clomipramine and desipramine in the treatment of developmental stuttering","volume":"56","author":"Gordon","year":"1995","journal-title":"J. Clin. Psychiatry"},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106427_bib41","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00005053-199207000-00008","article-title":"The effects of carbamazepine on stuttering","volume":"180","author":"Harvey","year":"1992","journal-title":"J. Nerv. Ment. Dis."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106427_bib42","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-0030-1265756","article-title":"What the literature tells us about Listeners\u02bc reactions to stuttering: implications for the clinical management of stuttering","volume":"31","author":"Healey","year":"2010","journal-title":"Semin. Speech Lang."},{"key":"10.1016\/j.neubiorev.2025.106427_bib43","article-title":"The cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","author":"Higgins","year":"2011","journal-title":"Cochrane Collab."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106427_bib44","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1177\/104012371602800110","article-title":"Case report of aripiprazole in the treatment of adolescent stuttering","volume":"28","author":"Hoang","year":"2016","journal-title":"Ann. Clin. Psychiatry. Off. J. Am. Acad. Clin. Psychiatr."},{"key":"10.1016\/j.neubiorev.2025.106427_bib45","article-title":"Pharmacological and dietary interventions for treating developmental stuttering: a systematic review","author":"Horton","year":"2023","journal-title":"PROSPERO"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106427_bib46","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1044\/1092-4388(2008\/048)","article-title":"Late childhood stuttering","volume":"51","author":"Howell","year":"2008","journal-title":"J. Speech Lang. Hear. Res."},{"key":"10.1016\/j.neubiorev.2025.106427_bib47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jfludis.2017.02.004","article-title":"A pilot study into a possible relationship between diet and stuttering","volume":"52","author":"Hum","year":"2017","journal-title":"J. Fluen. Disord."},{"key":"10.1016\/j.neubiorev.2025.106427_bib48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jfludis.2013.08.003","article-title":"Social anxiety disorder and stuttering: current status and future directions","volume":"40","author":"Iverach","year":"2014","journal-title":"J. Fluen. Disord."},{"issue":"8","key":"10.1016\/j.neubiorev.2025.106427_bib49","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJMoa0902630","article-title":"Mutations in the lysosomal Enzyme\u2013Targeting pathway and persistent stuttering [Article]","volume":"362","author":"Kang","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.neubiorev.2025.106427_bib50","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1044\/2017_JSLHR-S-16-0205","article-title":"The history of stuttering by 7 years of age: Follow-Up of a prospective community cohort","volume":"60","author":"Kefalianos","year":"2017","journal-title":"J. Speech Lang. Hear. Res. JSLHR"},{"key":"10.1016\/j.neubiorev.2025.106427_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcomdis.2022.106242","article-title":"Stuttering interventions for children, adolescents, and adults: a systematic review as a part of clinical guidelines","volume":"99","author":"Laiho","year":"2022","journal-title":"J. Commun. Disord."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106427_bib52","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/dmcn.14301","article-title":"Generic preference-based health-related quality of life in children with neurodevelopmental disorders: a scoping review","volume":"62","author":"Lamsal","year":"2020","journal-title":"Dev. Med. Child Neurol."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106427_bib53","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/10401239909147075","article-title":"Management of child and adolescent stuttering with olanzapine: three case reports","volume":"11","author":"Lavid","year":"1999","journal-title":"Ann. Clin. Psychiatry. Off. J. Am. Acad. Clin. Psychiatr."},{"key":"10.1016\/j.neubiorev.2025.106427_bib54","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1007\/s11136-019-02177-x","article-title":"Systematic review of the measurement properties of the depression anxiety stress Scales\u201321 by applying updated COSMIN methodology","volume":"28","author":"Lee","year":"2019","journal-title":"Qual. Life Res."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106427_bib55","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cortex.2009.02.017","article-title":"Altered effective connectivity and anomalous anatomy in the basal ganglia-thalamocortical circuit of stuttering speakers","volume":"46","author":"Lu","year":"2010","journal-title":"Cortex A J. Devoted Study Nerv. Syst. Behav."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106427_bib56","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/JCP.0b013e3181caebbe","article-title":"Exploratory randomized clinical study of pagoclone in persistent developmental stuttering: the examining pagoclone for persistent developmental stuttering study","volume":"30","author":"Maguire","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106427_bib57","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0010-440X(99)90132-3","article-title":"Stuttering: neuropsychiatric features measured by content analysis of speech and the effect of risperidone on stuttering severity","volume":"40","author":"Maguire","year":"1999","journal-title":"Compr. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106427_bib58","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/154733251903100310","article-title":"Ecopipam as a pharmacologic treatment of stuttering","volume":"31","author":"Maguire","year":"2019","journal-title":"Ann. Clin. Psychiatry. Off. J. Am. Acad. Clin. Psychiatr."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106427_bib59","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00004714-200008000-00013","article-title":"Risperidone for the treatment of stuttering","volume":"20","author":"Maguire","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106427_bib60","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/10401230490452834","article-title":"Olanzapine in the treatment of developmental stuttering: a double-blind, placebo-controlled trial","volume":"16","author":"Maguire","year":"2004","journal-title":"Ann. Clin. Psychiatry. Off. J. Am. Acad. Clin. Psychiatr."},{"key":"10.1016\/j.neubiorev.2025.106427_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.598949","article-title":"Investigation of risperidone treatment associated with enhanced brain activity in patients who stutter","volume":"15","author":"Maguire","year":"2021","journal-title":"Front Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106427_bib62","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jcomdis.2018.03.002","article-title":"Beliefs and behavioural intentions towards pharmacotherapy for stuttering: a survey of adults who stutter","volume":"73","author":"McGroarty","year":"2018","journal-title":"J. Commun. Disord."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106427_bib63","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/154733251803000110","article-title":"Stuttering and levetiracetam: case report and research proposal","volume":"30","author":"Mej\u00edas","year":"2018","journal-title":"Ann. Clin. Psychiatry. Off. J. Am. Acad. Clin. Psychiatr."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106427_bib64","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","article-title":"Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs","volume":"10","author":"Miyamoto","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106427_bib65","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"Bmj"},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106427_bib66","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1093\/brain\/awad314","article-title":"Stuttering associated with a pathogenic variant in the chaperone protein cyclophilin 40","volume":"146","author":"Morgan","year":"2023","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106427_bib67","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/JCP.0000000000000918","article-title":"Ziprasidone for the treatment of stuttering","volume":"38","author":"Munjal","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2025.106427_bib68","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1192\/bjp.130.4.370","article-title":"Haloperiodl in the treatment of stuttering","volume":"130","author":"Murray","year":"1977","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106427_bib69","first-page":"1","article-title":"The role of Patient-Reported outcomes to measure treatment satisfaction in drug development","author":"Navas","year":"2024","journal-title":"PatientPatientCent. Outcomes Res."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106427_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002492","article-title":"Knowns and unknowns about the neurobiology of stuttering","volume":"22","author":"Neef","year":"2024","journal-title":"PLoS Biol."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106427_bib71","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5498\/wjp.v12.i2.236","article-title":"Drug-induced stuttering: a comprehensive literature review","volume":"12","author":"Nikvarz","year":"2022","journal-title":"World J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106427_bib72","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"issue":"17","key":"10.1016\/j.neubiorev.2025.106427_bib73","doi-asserted-by":"crossref","first-page":"809","DOI":"10.5694\/j.1326-5377.1973.tb129781.x","article-title":"Stuttering. An investigation of haloperidol","volume":"2","author":"Quinn","year":"1973","journal-title":"Med. J. Aust."},{"issue":"10","key":"10.1016\/j.neubiorev.2025.106427_bib74","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1177\/1060028015596415","article-title":"Influence of methylphenidate on the frequency of stuttering: a randomized controlled trial","volume":"49","author":"Rabaeys","year":"2015","journal-title":"Ann. Pharmacother."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106427_bib75","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ajhg.2015.10.007","article-title":"Association between rare variants in AP4E1, a component of intracellular trafficking, and persistent stuttering","volume":"97","author":"Raza","year":"2015","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106427_bib76","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1542\/peds.2012-3067","article-title":"Natural history of stuttering to 4 years of age: a prospective Community-Based study","volume":"132","author":"Reilly","year":"2013","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106427_bib77","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.47552\/ijam.v13i4.3097","article-title":"Evaluation of comparative efficacy of guduchyadi leha versus kalyanaka leha as a standard control in the management of gadgada (Stuttering) in children: a randomized double-blind clinical study","volume":"13","author":"Rudey","year":"2022","journal-title":"Int. J. Ayurvedic Med."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106427_bib78","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4103\/0976-500X.72352","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"1","author":"Schulz","year":"2010","journal-title":"J. Pharmacol. Pharmacother."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106427_bib79","doi-asserted-by":"crossref","first-page":"27","DOI":"10.11613\/BM.2021.010502","article-title":"Sample size, power and effect size revisited: simplified and practical approaches in pre-clinical, clinical and laboratory studies","volume":"31","author":"Serdar","year":"2021","journal-title":"Biochem. Med."},{"key":"10.1016\/j.neubiorev.2025.106427_bib80","article-title":"Improvement of stuttering after administration of methylphenidate-a case report","volume":"31","author":"SheikhBahaei","year":"2022","journal-title":"Pers. Med. Psychiatry"},{"issue":"9","key":"10.1016\/j.neubiorev.2025.106427_bib81","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1044\/2020_JSLHR-20-00096","article-title":"Clinical characteristics associated with stuttering persistence: a Meta-Analysis","volume":"63","author":"Singer","year":"2020","journal-title":"J. Speech Lang. Hear. Res."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106427_bib82","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/dev.20009","article-title":"Development of functional synergies for speech motor coordination in childhood and adolescence","volume":"45","author":"Smith","year":"2004","journal-title":"Dev. Psychobiol."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106427_bib83","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jfludis.2005.09.004","article-title":"Treatment with medications affecting dopaminergic and serotonergic mechanisms: effects on fluency and anxiety in persons who stutter","volume":"30","author":"Stager","year":"2005","journal-title":"J. Fluen. Disord."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106427_bib84","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1044\/jshr.3803.516","article-title":"Fluency changes in persons who stutter following a double blind trial of clomipramine and desipramine","volume":"38","author":"Stager","year":"1995","journal-title":"J. Speech Hear. Res."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106427_bib85","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0010-440X(75)90022-X","article-title":"Haloperidol as a treatment for adult stuttering","volume":"16","author":"Swift","year":"1975","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106427_bib86","doi-asserted-by":"crossref","DOI":"10.1089\/can.2021.0060","article-title":"Cannabis improves stuttering: case report and interview with the patient","author":"Szejko","year":"2021","journal-title":"Cannabis cannabinoid Res."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106427_bib87","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/JCP.0b013e318205694f","article-title":"Risperidone reduces tic-like motor behaviors and linguistic dysfluencies in severe persistent developmental stuttering","volume":"31","author":"Tavano","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106427_bib88","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/14740338.2021.1867101","article-title":"Drug induced stuttering: pharmacovigilance data","volume":"20","author":"Trenque","year":"2021","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.neubiorev.2025.106427_bib89","article-title":"Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals","volume":"11","author":"Turner","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neubiorev.2025.106427_bib90","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3389\/fnins.2015.00297","article-title":"Metabolic issues in patients affected by schizophrenia: clinical characteristics and medical management","volume":"9","author":"Ventriglio","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106427_bib91","unstructured":"Innovation, Veritas Health Covidence systematic review software 2024 Melbourne, Australia."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106427_bib92","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/brain\/awm241","article-title":"Structural and functional abnormalities of the motor system in developmental stuttering","volume":"131","author":"Watkins","year":"2008","journal-title":"Brain A J. Neurol."},{"issue":"553","key":"10.1016\/j.neubiorev.2025.106427_bib93","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1192\/bjp.119.553.603","article-title":"Controlled trial of the treatment of 36 stutterers","volume":"119","author":"Wells","year":"1971","journal-title":"Br. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106427_bib94","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00001756-199702100-00037","article-title":"Increased dopamine activity associated with stuttering","volume":"8","author":"Wu","year":"1997","journal-title":"Neuroreport"}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763425004282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763425004282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:55:18Z","timestamp":1786971318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763425004282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":94,"alternative-id":["S0149763425004282"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106427","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological and dietary treatments for developmental stuttering: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106427","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106427"}}